Login
Users of this system, can login to view this document.
Enter the following information to request a copy of the document from the responsible person.
In silico design of potential drug lead compounds against multidrug–resistant Acinetobacter baumannii Class D carbapenemase OXA-23 and OXA-146 enzyme